SCHEMBL980073

SCHEMBL980073

c1ccc2c(c1)[nH]c1c(-c3nc(-c4cccc5c4[nH]c4ccccc45)nc(-c4cccc5c4[nH]c4ccccc45)n3)cccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.55
KIF11 P52732 4/20 0.53
PARP14 Q460N5 10/20 0.50
ALDH1A1 P00352 2/20 0.48
HSD17B10 Q99714 2/20 0.48
GPR3 P46089 1/20 0.48
GABRP O00591 2/20 0.47
GABRD O14764 2/20 0.47
GABRA1 P14867 2/20 0.47
GABRB1 P18505 2/20 0.47
GABRG2 P18507 2/20 0.47
GABRB3 P28472 2/20 0.47
GABRA5 P31644 2/20 0.47
GABRA3 P34903 2/20 0.47
GABRA2 P47869 2/20 0.47
GABRB2 P47870 2/20 0.47
GABRA4 P48169 2/20 0.47
GABRE P78334 2/20 0.47
GABRA6 Q16445 2/20 0.47
GABRG1 Q8N1C3 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23098999 0.92 TDO2 (0.50) BCHEKIF11PARP14TDO2HTR2B
SCHEMBL29522120 0.92 TDO2 (0.50) BCHEKIF11PARP14TDO2HTR2B
SCHEMBL28799492 0.92 BCHE (0.49) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL4091272 0.92 BCHE (0.49) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL4086466 0.90 BCHE (0.54) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL30136513 0.89 KIF11 (0.53) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL30519854 0.88 BCHE (0.49) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL26177838 0.88 KIF11 (0.54) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL28403751 0.88 BCHE (0.49) BCHEKIF11PARP14ALDH1A1HSD17B10
SCHEMBL29733506 0.86 KIF11 (0.63) BCHEKIF11PARP14ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090162764-A1 NITROGEN HETEROCYCLICS CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-06-25 US claimed
US-20090061337-A1 PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-03-05 US claimed
CN-112175172-B Efficient adsorption organic porous material for wastewater and preparation method thereof 四川冠慕思杨新材料科技有限公司 2023-08-04 CN disclosed
CN-112175172-A Efficient adsorption organic porous material for wastewater and preparation method thereof 四川冠慕思杨新材料科技有限公司 2021-01-05 CN disclosed
US-10629822-B2 Organic electroluminescent material and organic optoelectronic device Shanghai Tianma AM-OLED Co., Ltd. (CN) 2020-04-21 US disclosed
CN-106831743-B Organic electroluminescent material and organic photoelectric device 上海天马有机发光显示技术有限公司 2020-03-17 CN disclosed
CN-106831745-B Organic electroluminescent material and organic photoelectric device 上海天马有机发光显示技术有限公司 2020-01-14 CN disclosed
CN-105399696-B Organic electroluminescent compounds and organic photoelectric devices using the same 上海天马有机发光显示技术有限公司 2019-12-24 CN disclosed
US-10385059-B2 Organic electroluminescent material and organic optoelectronic device Shanghai Tianma AM-OLED Co., Ltd. (CN) 2019-08-20 US disclosed
US-10069082-B2 Organic electroluminescent compounds and organic optoelectronic devices comprising the same Shanghai Tianma AM-OLED Co., Ltd. (CN) 2018-09-04 US disclosed
US-9911932-B2 Organic electroluminescent material and organic optoelectronic device Shanghai Tianma AM-OLED Co., Ltd. (CN) 2018-03-06 US disclosed
CN-105189475-A Heterocyclic compounds and their use in electro-optical or opto-electronic devices POWER OLEDS LTD 2015-12-23 CN disclosed
CN-101128559-B Phosphorescent OLEDs with exciton blocking layer GLOBAL OLED TECHNOLOGY LLC 2014-08-13 CN disclosed
US-7914962-B2 Light stabilizer containing photoconductors XEROX CORPORATION (US) 2011-03-29 US disclosed
US-7867675-B2 Nitrogen heterocyclics in photoconductor charge transport layer XEROX CORPORATION (US) 2011-01-11 US disclosed
US-7670738-B2 Boron containing photoconductors XEROX CORPORATION (US) 2010-03-02 US disclosed
US-20090162764-A1 NITROGEN HETEROCYCLICS CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-06-25 US disclosed
US-20090061337-A1 PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-03-05 US disclosed
US-20090061338-A1 BORON CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-03-05 US disclosed
US-20090061336-A1 LIGHT STABILIZER CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10069082-B2 Organic electroluminescent compounds and organic optoelectronic devices comprising the same OR10J3, PPOX, OR51E2 BCHE 1616/4885KIF11 1790/4885PARP14 3260/4885
US-10385059-B2 Organic electroluminescent material and organic optoelectronic device OR10J3, C1S, F10 BCHE 2683/4885KIF11 3022/4885PARP14 4163/4885
US-10629822-B2 Organic electroluminescent material and organic optoelectronic device OR10J3, RPS10, H1-10 BCHE 2472/4885KIF11 2267/4885PARP14 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.